SOSTENOCEL
Live / Applied — Third extension granted (statement of use) (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 10 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98126048
- Mark type
- Stylized text
- Filed
- 10 Aug 2023
- Published for opposition
- 14 May 2024
- Attorney of record
- Niky Economy Syrengelas
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of vascular diseases and disorders, orthopedic diseases and disorders, eye diseases and disorders, and ENT diseases and disorders
Owner
- Caliber Therapeutics, LLC, New Hope, PA, US
- Caliber Therapeutics, LLC, New Hope, PA, US
Prosecution history
- 08 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2026 — SOU EXTENSION 3 GRANTED
- 07 Jan 2026 — SOU EXTENSION 3 FILED
- 07 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jun 2025 — SOU EXTENSION 2 GRANTED
- 10 Jun 2025 — SOU EXTENSION 2 FILED
- 10 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jan 2025 — SOU EXTENSION 1 GRANTED
- 03 Jan 2025 — SOU EXTENSION 1 FILED
- 03 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2024 — PUBLISHED FOR OPPOSITION